Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552578 · ClinicalTrials.gov registry record · Phase 4
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
A Phase 4 study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00552578 is a Phase 4 study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 12 participants.
The verdict
NCT00552578, a Phase 4 study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is designed to determine if different doses of buprenorphine (either tapering doses or steady doses) are effective in managing chronic, non-cancer pain in individuals who also are addicted to opiate pain medicines.
Interventions
- DRUG buprenorphine/naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00552578
The ClinicalTrials.gov registry entry for NCT00552578 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which buprenorphine/naloxone is the first listed.
NCT00552578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00552578 about?
NCT00552578 is a clinical study titled "Buprenorphine as a Treatment in Opiate Dependent Pain Patients". This study is designed to determine if different doses of buprenorphine (either tapering doses or steady doses) are effective in managing chronic, non-cancer pain in individuals who also are addicted to opiate pain medicines.
What is the current status of trial NCT00552578?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00552578?
The interventions under investigation include: buprenorphine/naloxone (DRUG).
Who is sponsoring clinical trial NCT00552578?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.